Nutraceuticals and Enteric Glial Cells

Until recently, glia were considered to be a structural support for neurons, however further investigations showed that glial cells are equally as important as neurons. Among many different types of glia, enteric glial cells (EGCs) found in the gastrointestinal tract, have been significantly underestimated, but proved to play an essential role in neuroprotection, immune system modulation and many other functions. They are also said to be remarkably altered in different physiopathological conditions. A nutraceutical is defined as any food substance or part of a food that provides medical or health benefits, including prevention and treatment of the disease. Following the description of these interesting peripheral glial cells and highlighting their role in physiological and pathological changes, this article reviews all the studies on the effects of nutraceuticals as modulators of their functions. Currently there are only a few studies available concerning the effects of nutraceuticals on EGCs. Most of them evaluated molecules with antioxidant properties in systemic conditions, whereas only a few studies have been performed using models of gastrointestinal disorders. Despite the scarcity of studies on the topic, all agree that nutraceuticals have the potential to be an interesting alternative in the prevention and/or treatment of enteric gliopathies (of systemic or local etiology) and their associated gastrointestinal conditions.

[1]  Brian D. Gulbransen,et al.  Enteric glial biology, intercellular signalling and roles in gastrointestinal disease , 2021, Nature Reviews Gastroenterology & Hepatology.

[2]  A. D. Pereira,et al.  Brazil Nut (Bertholletia excelsa H.B.K) Retards Gastric Emptying and Modulates Enteric Glial Cells in a Dose-Dependent Manner. , 2020, Journal of the American College of Nutrition.

[3]  D. Fried,et al.  Enteric Glia Modulate Macrophage Phenotype and Visceral Sensitivity following Inflammation , 2020, Cell reports.

[4]  M. Camilleri,et al.  Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  X. Hou,et al.  The Influence of Bifidobacterium bifidum and Bacteroides fragilis on Enteric Glial Cell–Derived Neurotrophic Factors and Inflammasome , 2020, Inflammation.

[6]  Whitney Mortensen,et al.  Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature , 2020, The Annals of pharmacotherapy.

[7]  R. Capasso,et al.  Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals? , 2020, International journal of molecular sciences.

[8]  M. Pietra,et al.  Localization of cannabinoid and cannabinoid related receptors in the cat gastrointestinal tract , 2020, Histochemistry and Cell Biology.

[9]  Heng Li,et al.  Protective role of berberine on ulcerative colitis through modulating enteric glial cells–intestinal epithelial cells–immune cells interactions , 2019, Acta pharmaceutica Sinica. B.

[10]  C. Bersani-Amado,et al.  Rheumatoid arthritis induces enteric neurodegeneration and jejunal inflammation, and quercetin promotes neuroprotective and anti-inflammatory actions. , 2019, Life sciences.

[11]  F. Kirchhoff,et al.  Enteric Glia: S100, GFAP, and Beyond , 2019, Anatomical record.

[12]  M. Saghafi-Asl,et al.  The novel insight into anti-inflammatory and anxiolytic effects of psychobiotics in diabetic rats: possible link between gut microbiota and brain regions , 2019, European Journal of Nutrition.

[13]  Y. Kitamura,et al.  Effects of Enteric Environmental Modification by Coffee Components on Neurodegeneration in Rotenone-Treated Mice , 2019, Cells.

[14]  Brian D. Gulbransen,et al.  Enteric Glia: A New Player in Abdominal Pain , 2018, Cellular and molecular gastroenterology and hepatology.

[15]  Renata Longhini,et al.  Ethyl Acetate Fraction from Trichilia catigua Confers Partial Neuroprotection in Components of the Enteric Innervation of the Jejunum in Diabetic Rats. , 2019, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

[16]  D. Liu,et al.  Enteric glial cell activation protects enteric neurons from damage due to diabetes in part via the promotion of neurotrophic factor release , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[17]  M. Natali,et al.  Resveratrol promotes neuroprotection and attenuates oxidative and nitrosative stress in the small intestine in diabetic rats. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  T. Dinis,et al.  Dietary polyphenols: A novel strategy to modulate microbiota-gut-brain axis , 2018, Trends in Food Science & Technology.

[19]  M. Forni,et al.  Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract , 2018, Histochemistry and Cell Biology.

[20]  Wei Zhang,et al.  Butyrate promotes visceral hypersensitivity in an IBS‐like model via enteric glial cell‐derived nerve growth factor , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[21]  P. Naveilhan,et al.  Glioplasticity in irritable bowel syndrome , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[22]  R. Cuomo,et al.  HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia , 2018, Journal of Neuroinflammation.

[23]  P. Naveilhan,et al.  The multiple faces of inflammatory enteric glial cells: is Crohn's disease a gliopathy? , 2018, American journal of physiology. Gastrointestinal and liver physiology.

[24]  J. Irache,et al.  Evaluation of the treatment with resveratrol-loaded nanoparticles in intestinal injury model caused by ischemia and reperfusion. , 2018, Toxicology.

[25]  K. Fettucciari,et al.  Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum? , 2018, Cellular and Molecular Life Sciences.

[26]  M. Camilleri,et al.  Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. , 2017, Gastroenterology.

[27]  C. Hermes-Uliana,et al.  Antioxidant Effects of the Quercetin in the Jejunal Myenteric Innervation of Diabetic Rats , 2017, Front. Med..

[28]  David V. Gioe,et al.  Enteric glial cells are susceptible to Clostridium difficile toxin B , 2016, Cellular and Molecular Life Sciences.

[29]  L. Schneider,et al.  Resveratrol promotes myenteric neuroprotection in the ileum of rats after ischemia-reperfusion injury. , 2016, Life sciences.

[30]  David V. Gioe,et al.  Enteric glial cells are susceptible to Clostridium difficile toxin B , 2016, Cellular and Molecular Life Sciences.

[31]  K. Tominaga,et al.  Concentration of Glial Cell Line-Derived Neurotrophic Factor Positively Correlates with Symptoms in Functional Dyspepsia , 2016, Digestive Diseases and Sciences.

[32]  J. Machan,et al.  A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection , 2016, Journal of clinical gastroenterology.

[33]  D. R. Linden,et al.  Desired and side effects of the supplementation with l-glutamine and l-glutathione in enteric glia of diabetic rats. , 2016, Acta histochemica.

[34]  M. Neunlist,et al.  The arachidonic acid metabolite 11β-ProstaglandinF2α controls intestinal epithelial healing: deficiency in patients with Crohn’s disease , 2016, Scientific Reports.

[35]  B. Niesler,et al.  Activation of Myenteric Glia during Acute Inflammation In Vitro and In Vivo , 2016, PloS one.

[36]  X. Zuo,et al.  BDNF contributes to IBS-like colonic hypersensitivity via activating the enteroglia-nerve unit , 2016, Scientific Reports.

[37]  S. Wehner,et al.  Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases , 2015, Inflammatory bowel diseases.

[38]  B. Khakh,et al.  Diversity of astrocyte functions and phenotypes in neural circuits , 2015, Nature Neuroscience.

[39]  R. Peralta,et al.  Aqueous Extract of Agaricus blazei Murrill Prevents Age-Related Changes in the Myenteric Plexus of the Jejunum in Rats , 2015, Evidence-based complementary and alternative medicine : eCAM.

[40]  B. Needleman,et al.  63 Gliomodulation of Neuronal and Motor Behavior in the Human GI Tract , 2015 .

[41]  K. Sharkey Emerging roles for enteric glia in gastrointestinal disorders. , 2015, The Journal of clinical investigation.

[42]  E. Hol,et al.  Enteric GFAP expression and phosphorylation in Parkinson's disease , 2014, Journal of neurochemistry.

[43]  Glenn R. Gibson,et al.  The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014 .

[44]  A. Bracht,et al.  Food restriction enhances oxidative status in aging rats with neuroprotective effects on myenteric neuron populations in the proximal colon , 2014, Experimental Gerontology.

[45]  V. Parpura,et al.  Ca2+ responses in enteric glia are mediated by connexin-43 hemichannels and modulate colonic transit in mice. , 2014, Gastroenterology.

[46]  W. D. de Jonge,et al.  Postoperative ileus involves interleukin-1 receptor signaling in enteric glia. , 2014, Gastroenterology.

[47]  B. Olde,et al.  Enteric Neuropathy Can Be Induced by High Fat Diet In Vivo and Palmitic Acid Exposure In Vitro , 2013, PloS one.

[48]  D. R. Linden,et al.  Diabetic neuropathy: an evaluation of the use of quercetin in the cecum of rats. , 2013, World journal of gastroenterology.

[49]  O. Balemba,et al.  High-fat diet and age-dependent effects on enteric glial cell populations of mouse small intestine , 2013, Autonomic Neuroscience.

[50]  R. Cuomo,et al.  Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation , 2013, Gut.

[51]  P. Pasricha,et al.  3‐D imaging, illustration, and quantitation of enteric glial network in transparent human colon mucosa , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[52]  D. Devos,et al.  Colonic inflammation in Parkinson's disease , 2013, Neurobiology of Disease.

[53]  R. Cuomo,et al.  Enteroglial-derived S100B protein integrates bacteria-induced Toll-like receptor signalling in human enteric glial cells , 2013, Gut.

[54]  J. Zanoni,et al.  Neuroprotective Effect of Quercetin on the Duodenum Enteric Nervous System of Streptozotocin-Induced Diabetic Rats , 2012, Digestive Diseases and Sciences.

[55]  K. Whelan,et al.  Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. , 2012, The Journal of nutrition.

[56]  I. Hall,et al.  Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα , 2012, Gut.

[57]  M. Neunlist,et al.  The omega‐6 fatty acid derivative 15‐deoxy‐Δ12,14‐prostaglandin J2 is involved in neuroprotection by enteric glial cells against oxidative stress , 2012, The Journal of physiology.

[58]  S. B. des Varannes,et al.  Diet‐induced obesity has neuroprotective effects in murine gastric enteric nervous system: involvement of leptin and glial cell line‐derived neurotrophic factor , 2012, The Journal of physiology.

[59]  Marcus J Claesson,et al.  An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota , 2011, Gut.

[60]  R. Cuomo,et al.  Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis , 2011, PloS one.

[61]  S. Prusiner,et al.  Prion Uptake in the Gut: Identification of the First Uptake and Replication Sites , 2011, PLoS pathogens.

[62]  Sebastian Tims,et al.  Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. , 2011, Gastroenterology.

[63]  X. Zuo,et al.  Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome , 2011, Gut.

[64]  R. Cuomo,et al.  Proinflammatory stimuli activates human‐derived enteroglial cells and induces autocrine nitric oxide production , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[65]  G. Lazzeri,et al.  Transmission of prions within the gut and towards the central nervous system , 2011, Prion.

[66]  J. Zanoni,et al.  l-Glutamine Supplementation Prevents Myenteric Neuron Loss and Has Gliatrophic Effects in the Ileum of Diabetic Rats , 2011, Digestive Diseases and Sciences.

[67]  R. Cuomo,et al.  S100B protein in the gut: the evidence for enteroglial-sustained intestinal inflammation. , 2011, World journal of gastroenterology.

[68]  T. Savidge,et al.  Enteric glia promote intestinal mucosal healing via activation of focal adhesion kinase and release of proEGF. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[69]  M. Steinkamp,et al.  Distribution of enteric glia and GDNF during gut inflammation , 2011, BMC gastroenterology.

[70]  P. Sansonetti,et al.  Enteric glia protect against Shigella flexneri invasion in intestinal epithelial cells: a role for S-nitrosoglutathione , 2010, Gut.

[71]  D. Zhang,et al.  Glial‐derived neurotrophic factor regulates intestinal epithelial barrier function and inflammation and is therapeutic for murine colitis , 2010, The Journal of pathology.

[72]  G. Savoini,et al.  The chemical code of porcine enteric neurons and the number of enteric glial cells are altered by dietary probiotics , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[73]  M. Denis,et al.  Enteric glia modulate epithelial cell proliferation and differentiation through 15‐deoxy‐Δ12,14‐prostaglandin J2 , 2010, The Journal of physiology.

[74]  G. Adler,et al.  The endothelin axis influences enteric glia cell functions. , 2010, Medical science monitor : international medical journal of experimental and clinical research.

[75]  Gun-Hee Kim,et al.  Quercetin accumulation by chronic administration causes the caspase‐3 activation in liver and brain of mice , 2010, BioFactors.

[76]  F. D'armiento,et al.  Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial‐derived S100B protein , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[77]  V. Pachnis,et al.  Development of the enteric nervous system: bringing together cells, signals and genes , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[78]  J. Timmermans,et al.  Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[79]  V. Villanacci,et al.  Enteric nervous system abnormalities in inflammatory bowel diseases , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[80]  M. Wegner,et al.  Quantitative assessment of glial cells in the human and guinea pig enteric nervous system with an anti‐Sox8/9/10 antibody , 2008, The Journal of comparative neurology.

[81]  S. Ito,et al.  Interleukin-1β enhances the action of bradykinin in rat myenteric neurons through up-regulation of glial B1 receptor expression , 2008, Neuroscience.

[82]  J. Bornstein Purinergic mechanisms in the control of gastrointestinal motility , 2008, Purinergic Signalling.

[83]  R. Brentani,et al.  Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation , 2007, Journal of neurochemistry.

[84]  E. Benarroch,et al.  Enteric nervous system , 2007, Neurology.

[85]  Y. Nasser,et al.  Expression of a functional metabotropic glutamate receptor 5 on enteric glia is altered in states of inflammation , 2007, Glia.

[86]  M. Sofroniew,et al.  Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. , 2007, Gastroenterology.

[87]  C. Bilder,et al.  The Enteric Nervous System in Chagasic and Idiopathic Megacolon , 2007, The American journal of surgical pathology.

[88]  G. Nesi,et al.  Colonic neuropathological aspects in patients with intractable constipation due to obstructed defecation , 2007, Modern Pathology.

[89]  G. Adler,et al.  Nerve Growth Factor Secretion in Cultured Enteric Glia Cells is Modulated by Proinflammatory Cytokines , 2006, Journal of neuroendocrinology.

[90]  W. MacNaughton,et al.  Role of enteric glia in intestinal physiology: effects of the gliotoxin fluorocitrate on motor and secretory function. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[91]  C. Maurer,et al.  Enteric neuropathology of the terminal ileum in patients with intractable slow-transit constipation. , 2006, Human pathology.

[92]  G. Burnstock,et al.  Region-specific distribution of the P2Y4 receptor in enteric glial cells and interstitial cells of Cajal within the guinea-pig gastrointestinal tract , 2006, Autonomic Neuroscience.

[93]  G. Adler,et al.  Proinflammatory cytokines induce neurotrophic factor expression in enteric glia: a key to the regulation of epithelial apoptosis in Crohn's disease. , 2006, Inflammatory bowel diseases.

[94]  J. Galmiche,et al.  Changes in enteric neurone phenotype and intestinal functions in a transgenic mouse model of enteric glia disruption , 2005, Gut.

[95]  C. Maurer,et al.  The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation , 2005, Gut.

[96]  T. Powley,et al.  Loss of glia and neurons in the myenteric plexus of the aged Fischer 344 rat , 2004, Anatomy and Embryology.

[97]  G. Adler,et al.  Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia , 2004, Gut.

[98]  A. Reichenbach,et al.  Morphology of horseradish peroxidase (HRP)-injected glial cells in the myenteric plexus of the guinea-pig , 1994, Cell and Tissue Research.

[99]  S. Lecchini,et al.  Evidence for a glutamatergic modulation of the cholinergic function in the human enteric nervous system via NMDA receptors. , 2003, European journal of pharmacology.

[100]  T. Seufferlein,et al.  Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells. , 2003, Gastroenterology.

[101]  S. Schiffmann,et al.  Glial cells, but not interstitial cells, express P2X7, an ionotropic purinergic receptor, in rat gastrointestinal musculature , 2003, Cell and Tissue Research.

[102]  G. Ubeaud,et al.  Anti‐ and pro‐oxidant activity of rutin and quercetin derivatives , 2003, The Journal of pharmacy and pharmacology.

[103]  E. Fletcher,et al.  Neuronal and glial localization of GABA transporter immunoreactivity in the myenteric plexus , 2002, Cell and Tissue Research.

[104]  H. Lassmann,et al.  Enterocolitis induced by autoimmune targeting of enteric glial cells: A possible mechanism in Crohn's disease? , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[105]  R. Semba,et al.  L-Arginine Immunoreactive Enteric Glial Cells in the Enteric Nervous System of Rat Ileum , 2001, Neurosignals.

[106]  R. Spiller,et al.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acuteCampylobacter enteritis and in post-dysenteric irritable bowel syndrome , 2000, Gut.

[107]  J. Galligan,et al.  Multiple mechanisms of fast excitatory synaptic transmission in the enteric nervous system. , 2000, Journal of the autonomic nervous system.

[108]  L. Mucke,et al.  Fulminant Jejuno-Ileitis following Ablation of Enteric Glia in Adult Transgenic Mice , 1998, Cell.

[109]  K. Sharkey,et al.  Effects of inflammation on cell proliferation in the myenteric plexus of the guinea-pig ileum , 1997, Cell and Tissue Research.

[110]  J. Hoehner,et al.  Localization of neurotrophins and their high-affinity receptors during human enteric nervous system development. , 1996, Gastroenterology.

[111]  M. Mulholland,et al.  Enteric Glia Exhibit P2U Receptors that Increase Cytosolic Calcium by a Phospholipase C‐Dependent Mechanism , 1996, Journal of neurochemistry.

[112]  M. Eddleston,et al.  Molecular profile of reactive astrocytes—Implications for their role in neurologic disease , 1993, Neuroscience.

[113]  P. Rutgeerts,et al.  Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. , 1992, Gastroenterology.

[114]  R. Semba,et al.  Evidence for the presence of l-arginine in the glial components of the peripheral nervous system , 1991, Brain Research.

[115]  M. Hanani,et al.  Glial cells in the guinea pig myenteric plexus are dye coupled , 1989, Brain Research.

[116]  K. Koretz,et al.  Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease. , 1987, The American journal of pathology.

[117]  R. Mirsky,et al.  Astrocyte-like glia in the peripheral nervous system: an immunohistochemical study of enteric glia , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[118]  F. Michetti,et al.  Evidence for the presence of S-100 protein in the glial component of the human enteric nervous system , 1982, Nature.

[119]  R. Mirsky,et al.  Glial cells in the enteric nervous system contain glial fibrillary acidic protein , 1980, Nature.